
Sign up to save your podcasts
Or
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Recursion Pharmaceuticals.
5
1919 ratings
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Recursion Pharmaceuticals.
30,112 Listeners
116 Listeners
84 Listeners